Kapellou Olga
Neonatal Unit, Homerton University Hospital NHS Foundation Trust, London, UK.
BMJ Clin Evid. 2011 Apr 5;2011:0313.
Preterm or ill neonates may undergo 1 to 21 heel punctures or venepunctures a day. These punctures are likely to be painful. Heel punctures comprise 61% to 87% and venepunctures comprise 8% to 13% of the invasive procedures performed on ill infants. Analgesics are rarely given specifically for blood sampling procedures, but 5% to 19% of infants receive analgesia for other indications.
We conducted a systematic review and aimed to answer the following clinical question: What are the effects of interventions to reduce pain-related distress and morbidity during venepuncture in preterm or term babies aged under 12 months in a neonatal unit? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
We found 20 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
In this systematic review we present information relating to the effectiveness and safety of the following interventions: oral sweet solutions; pacifiers; and topical anaesthetics (lidocaine-prilocaine cream, tetracaine).
早产或患病新生儿一天可能要接受1至21次足跟采血或静脉穿刺。这些穿刺很可能会带来疼痛。在患病婴儿所进行的侵入性操作中,足跟采血占61%至87%,静脉穿刺占8%至13%。很少专门针对采血操作给予镇痛药,但5%至19%的婴儿因其他指征接受了镇痛。
我们进行了一项系统评价,旨在回答以下临床问题:在新生儿病房,对于12个月以下的早产或足月婴儿,减少静脉穿刺期间与疼痛相关的痛苦和发病率的干预措施有哪些效果?我们检索了:截至2010年6月的医学期刊数据库(Medline)、荷兰医学文摘数据库(Embase)、考克兰图书馆及其他重要数据库(临床证据综述会定期更新,请查看我们的网站获取本综述的最新版本)。我们纳入了来自美国食品药品监督管理局(FDA)和英国药品与保健品监管局(MHRA)等相关组织的危害警示。
我们找到了20项符合我们纳入标准的系统评价、随机对照试验或观察性研究。我们对干预措施的证据质量进行了GRADE评估。
在本系统评价中,我们呈现了以下干预措施的有效性和安全性相关信息:口服甜味溶液;安抚奶嘴;以及局部麻醉剂(利多卡因 - 丙胺卡因乳膏、丁卡因)。